Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s displayed system “Revision” number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision updated to v3.5.2; the previous v3.5.0 revision was removed.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check57 days agoChange DetectedFooter Revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 with no visible changes to study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page shows a minor software version update from v3.4.0 to v3.4.1 with no visible changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.